Verma is best-known as the designer of Indiana's Medicaid expansion program, which features a lockout provision for those who fail to pay premiums.
The Senate today voted 55-43 to confirm President Donald Trump’s nominee to run CMS.
Seema Verma will take over the giant agency that operates Medicare and Medicaid and is the nation’s largest payer, setting policy for those programs and the blueprint that most other commercial plans follow.
An ally of many conservatives, she is best known as the designer of the alternate Medicaid plan developed in Indiana under former governor Republican Governor Mitch Daniels, and carried to the fruition by now-Vice President Mike Pence. She has also been involved in developing work requirements to overhaul the Medicaid expansion program for Kentucky for its new governor, Matt Bevin.
As Indiana governor, Pence modified Daniels’ program for Medicaid expansion, which featured premium contributions, incentives for healthy behaviors, and a benefit lock-out if they failed to pay premium. However, there have been recent accusations that Healthy Indiana 2.0, as the program is called, may have fudge the numbers when evaluating its performance.
Critics of Verma disagree with her approach to making the poor pay more to get less from Medicaid. And Democrats said they struggled to get complete answers to their questions.
“What I read was a lot of happy talk that didn't amount to much substance," Sen. Ron Wyden. D-Oregon, has said.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More
The Impact of Cost Sharing on High-Value Care
March 14th 2025Michael Chernew, PhD, professor of health care policy and director of the Healthcare Markets and Regulation Lab, Harvard Medical School, shares how cost-sharing policies shape access to critical health care services and influence value-based insurance design.
Read More
A Focus on MAHA, Lasting Changes to Health Care Programs for Trump’s Second Term
March 13th 2025The second Trump administration is expected to bring changes to Medicaid, Medicare Advantage, and the health insurance exchanges, as well as highlight the Make America Healthy Again (MAHA) movement, speakers at the Value-Based Insurance Design Summit said.
Read More